Mike Hollan

Experts discuss how the upcoming election is impacting the pharma industry, and how either party’s victory could change the landscape in the following years.

Tala Fakhouri spoke at the conference about FDA’s approach to determining when it even needs to regulate the usage of AI in the pharma industry.

Industry experts gather to discuss the current investor market and how the IRA may impact the industry in the coming years.

The platform will use AI technology to provide pharmacists with more tools.

Carta Healthcare’s co-founder discusses how a recent ruling on non-compete clauses may help alleviate the coming nursing shortage.

The NABIP expressed frustration at CMS’ statement for placing blame on brokers and agents and not acknowledging evidence that switches were made by automated programs.

The CEO of ActiGraph discusses how these devices are changing patient monitoring in clinical trials.

Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.

A greater shift from paper records and physical assets is achievable.

From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.

The National Institute for Public Employee Healthcare Policy attributed the importance to the rising cost of health care.

Respondents said they were concerned about their own mental health or the mental health of another person at higher rates since 2022.

Cencora’s vice president of product management, global products & solutions Beth Riggio discusses the issues the industry faces with recalls and how it can improve.

The new care center will offer primary care services to uninsured and underinsured patients in the Wilmington, North Carolina, area.

RxLink will incorporate Cost Plus’ prices into its drug pricing platform MedMap.

The founder and CEO of UpScriptHealth discusses the issues causing the shortage and how recent decisions from the DEA may help solve the issue.

Batra will lead the company’s clinical strategy.

Dr. Lewis used the AI-powered device on a patient with severe lumbar stenosis.

The two companies will work together to develop gene therapies in oncology.

The plan is focused on providing financial incentives for treatments that improve the patients’ health equity.

The CEO of Outcomes discusses how local pharmacies are playing an important role in improving health equity.

The vice president of technology strategy & strategic partnerships at Syneos Health discusses how new digital technologies are changing the ways that data is collected, shared, analyzed.

The CEO of NewYorkBIO discusses why investors continue to flock to New York in the life sciences industry.

Blankenship, vice president of policy initiatives and advocacy at The Academy of Nutrition and Dietetics, discusses how AOMs can play a role in creating strategies to manage the obesity epidemic.

The lawsuit, filed the department of labor, alleges that Blue Cross improperly collected provider taxes from self-funded employer health plans.

PanOmiQ is referred to as the fasted technology of its kind by the company.

Melton, VP of scientific operations and development at Slope, discusses how new technologies can be used to ensure data is accurate.

The center will offer local residents with opportunities and training to enter the pharmacy work force.

Sanders wrote a letter to Novo Nordisk announcing the investigation.

LabConnect will utilize the consulting firm’s assets to improve its clinical trial services.